The Molecular Imaging & Image-Guided Therapy (MIIGT) research program, led by Prof. Mosa Alhamami, focuses on developing advanced image-guided focused ultrasound technologies for interventional applications, advancing cancer imaging through innovative molecular, cellular, and quantitative MRI approaches, and engineering nanomaterials designed to improve the targeted delivery of contrast agents and cancer therapeutics.
Additionally, we are actively exploring artificial intelligence (AI) applications within radiology – with a particular focus on interventional radiology – to optimize clinical workflows, enhance patient safety, improve operational efficiency, strengthen radiation management, and elevate the overall quality of imaging outcomes through informed, data-driven decision-making.
MISSION STATEMENT
Our mission is to advance precision imaging and interventional care through the development of image-guided focused ultrasound therapies for non-invasive or minimally invasive procedures, molecular and quantitative imaging techniques for cancer detection and characterization, and AI-driven tools to streamline workflows, enhance patient safety, and optimize radiation utilization.
We are newly established at the University of Wisconsin–Madison. For more information about available research projects or to explore collaboration opportunities, please feel free to contact us at alhamami@wisc.edu.